Review
Neuroblastoma today
Affiliations
- PMID: 3056532
Item in Clipboard
Review
Neuroblastoma today
Biomed Pharmacother.
1988.
Abstract
Notwithstanding the progress made in radiology, nuclear medicine, immunohematology and genetics for more accurate diagnosis and staging in neuroblastoma and the availability of general new efficacious cytostatic drugs, the prognosis of children over 1 yr with advanced disease has remained poor. New refinements in therapeutics with multiagent regimens, massive chemotherapy followed by autologous bone marrow transplantation treatment, with or without immunomagnetic purging, and/or total body irradiation have improved response rate and disease-free survival in metastatic patients, but their effect on long-term survival needs further evaluation.
Similar articles
-
Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):58-60. Q J Nucl Med. 1995. PMID: 9002751
-
The treatment of neuroblastoma with [131I]MIBG at diagnosis.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):65-8. Q J Nucl Med. 1995. PMID: 9002753
-
[Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].Klin Padiatr. 1986 May-Jun;198(3):230-6. doi: 10.1055/s-2008-1026882. Klin Padiatr. 1986. PMID: 3723987 German.
-
[Focus on neuroblastoma in 1987. 2: Treatment].Pediatrie. 1987;42(4):231-9. Pediatrie. 1987. PMID: 3313264 Review. French.
-
[Research approach in the diagnosis and treatment of neuroblastoma].Presse Med. 1988 May 7;17(17):839-40. Presse Med. 1988. PMID: 2968578 Review. French. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical